Keyphrases
Hemoglobin A1c (HbA1c)
60%
Type 2 Diabetic Patients
57%
Type 2 Diabetes Mellitus (T2DM)
50%
Type 1 Diabetes Mellitus (T1DM)
44%
Type 2 Diabetes Mellitus Patients
41%
Autonomic Neuropathy
33%
LDL Cholesterol Level
33%
Ophtalmopathy
33%
Transforming Growth factor-β1 (TGF-β1)
33%
Lp(a)
33%
Soluble CD163
33%
Small Dense LDL Cholesterol
33%
SdLDL
33%
Transforming Growth Factor-β
33%
Patients with Diabetes Mellitus
33%
Arterial Stiffness
33%
Lipoproteins
33%
Non-insulin-dependent Diabetes Mellitus (NIDDM)
33%
Malnutrition
33%
Peripheral Neuropathy
33%
Thyrotropin Receptor Antibody (TRAb)
33%
Diabetes Mellitus Type 2
33%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
33%
Graves' Disease
33%
Ophthalmopathy
25%
Mesenchymal Stem Cells
22%
C-peptide
22%
After Injection
22%
Brachial-ankle Pulse Wave Velocity (baPWV)
20%
Plasma Parameters
19%
Graves
16%
CD163
14%
Cholesterol Levels
14%
HbA1c Levels
14%
Enzyme-linked Immunosorbent Assay (ELISA)
14%
Cardiovascular Disease
13%
Surabaya
13%
Metabolic
12%
Surrogate Cells
11%
Phase I Clinical Trial
11%
Glucose-insulin System
11%
Fasting Plasma Glucose
11%
Focus of Attention
11%
Adult Tissues
11%
Stem Cell-derived
11%
Diabetic Patients
11%
Prandial
11%
Blood Glucose
11%
Catheterization
11%
Stem Cell Transplantation
11%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Diabetes Mellitus
55%
Hemoglobin A1c
43%
Blood Glucose
33%
Transforming Growth Factor Beta1
33%
Lipoprotein(A)
33%
Adipose-Derived Mesenchymal Stem Cell
33%
Arterial Stiffness
33%
Patient with Diabetes
33%
Patient with Type 2 Diabetes
24%
Pulse Wave Velocity
23%
Mesenchymal Stem Cell
22%
Diabetes
14%
Stem Cell Therapy
11%
Mesenchymal Stem Cell Transplantation
11%
Insulin Treatment
11%
C-Peptide
11%
Clinical Trial
11%
Catheterization
11%
Lipoprotein
9%
Enzyme Linked Immunosorbent Assay
8%
Pharmacology, Toxicology and Pharmaceutical Science
Non Insulin Dependent Diabetes Mellitus
100%
Hemoglobin A1c
59%
Receptor Antibody
33%
Graves Disease
33%
Thyrotropin Receptor
33%
Low Density Lipoprotein Cholesterol
33%
Transforming Growth Factor Beta1
33%
Eye Disease
27%
Diabetes Mellitus
22%
C Peptide
22%
Enzyme-Linked Immunosorbent Assay
19%
Atherosclerosis
16%
Cardiovascular Disease
16%
Cross-Sectional Study
13%
Clinical Trial
11%
Endocrine Ophthalmopathy
11%
Diseases
11%
Enzyme Immunoassay
8%
Biological Marker
8%
Monoclonal Antibody
8%
Lipoprotein
8%
Calorimetry
8%
Thyroid Disease
5%
Thyrotropin
5%